Furthermore, promotion of Hsp90-Acsl4 contributed to efficient tumor inhibition and obvious survival improvement, due to the increasing sensitivity of glioma to erastin-induced ferroptosis. The gene discussed is ACSL4; the disease is central nervous system cancer.